Stockholm, December 6, 2024 – Intervacc AB (publ) announces that Strangvac®, a vaccine against equine strangles, is now back in stock for delivery in all European markets where the vaccine has been ... Read more
The Group in summary
Read moreStockholm, November 11, 2024 – Intervacc AB (publ) will publish its interim report for the period January to September 2024 on Thursday 14 November 2024, at 08:30 CET. CEO Jonas Sohlman and CFO Jan Persson will present ... Read more
Stockholm, October 21, 2024 – Intervacc AB (publ) announces that the shortage situation for the equine strangles vaccine Strangvac® in Sweden has been resolved and the vaccine is again in stock for ... Read more
Stockholm, September 20, 2024 - Intervacc AB (publ) predicts that the vaccine Strangvac®, which is approved for sale in Europe and the UK, may be out-of-stock for a short period from the 1st October 2024. The ... Read more
